Journal of Gastrointestinal Surgery

, Volume 13, Issue 3, pp 492–497 | Cite as

Clinicopathologic Characteristics of Hepatocellular Carcinoma with Bile Duct Invasion

  • Naoki Ikenaga
  • Kazuo Chijiiwa
  • Kazuhiro Otani
  • Jiro Ohuchida
  • Shuichiro Uchiyama
  • Kazuhiro Kondo
original article
First Online:
Received:
Accepted:

Abstract

To clarify the characteristics of hepatocellular carcinoma (HCC) with bile duct invasion, we retrospectively analyzed clinical features and surgical outcome of HCC with bile duct invasion (b+ group, n = 15) compared to those without bile duct invasion (b− group, n = 256). In the b+ group, four patients (27%) showed obstructive jaundice, and a diagnosis of bile duct invasion was obtained preoperatively in seven patients (47%). The levels of serum bilirubin and carbohydrate antigen 19–9 were significantly higher in the b+ group. Macroscopically, confluent multinodular type and infiltrative type were predominant in the b+ group (P = 0.002). Microscopically, capsule infiltration (P = 0.040) and intrahepatic metastasis (P = 0.013) were predominant in the b+ group. Portal vein invasion was associated significantly with the b+ group (P = 0.004); however, the frequency of hepatic vein invasion was similar (P = 0.096). The median survival after resection was significantly shorter in the b+ group than in the b− group (11.4 vs. 56.1 months, P = 0.002), and eight of 11 intrahepatic recurrences in the b+ group occurred within 3 months after surgery. HCC with bile duct invasion has an infiltrative nature and a high risk of intrahepatic recurrence, resulting in poor prognosis.

Keywords

Hepatocellular carcinoma Bile duct invasion Thrombus Jaundice Clinicopathologic characteristics 
This is a preview of subscription content, log in to check access.

References

  1. 1.
    Kondo K, Chijiiwa K, Makino I, Kai M, Maehara N, Ohuchida J, Naganuma S. Risk factors for early death after liver resection in patients with solitary hepatocellular carcinoma. J Hepatobiliary Pancreat Surg 2005;12:399–404. doi: 10.1007/s00534-005-1009-9.PubMedCrossRefGoogle Scholar
  2. 2.
    Lin TY, Chen KM, Chen YR, Lin WS, Wang TH, Sung JL. Icteric type hepatoma. Med Chir Dig 1975;4:267–270.PubMedGoogle Scholar
  3. 3.
    Tsuzuki T, Ogata Y, Iida S, Kasajima M, Takahashi S. Hepatoma with obstructive jaundice due to the migration of a tumor mass in the biliary tract: report of a successful resection. Surgery 1979;85:593–598.PubMedGoogle Scholar
  4. 4.
    Satoh S, Ikai I, Honda G, Okabe H, Takeyama O, Yamamoto Y, Yamamoto N, Iimuro Y, Shimahara Y, Yamaoka Y. Clinicopathologic evaluation of hepatocellular carcinoma with bile duct thrombi. Surgery 2000;128:779–783. doi: 10.1067/msy.2000.108659.PubMedCrossRefGoogle Scholar
  5. 5.
    Yeh CN, Jan YY, Lee WC, Chen MF. Hepatic resection for hepatocellular carcinoma with obstructive jaundice due to biliary tumor thrombi. World J Surg 2004;28:471–475. doi: 10.1007/s00268-004-7185-y.PubMedCrossRefGoogle Scholar
  6. 6.
    Lau W, Leung K, Leung TW, Liew CT, Chan MS, Yu SC, Li AK. A logical approach to hepatocellular carcinoma presenting with jaundice. Ann Surg 1997;225:281–285. doi: 10.1097/00000658-199703000-00007.PubMedCrossRefGoogle Scholar
  7. 7.
    Kubota K, Makuuchi M, Kusaka K, Kobayashi T, Miki K, Hasegawa K, Harihara Y, Takayama T. Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors. Hepatology 1997;26:1176–1181.PubMedGoogle Scholar
  8. 8.
    Liver Cancer Study Group of Japan. General Rules for the Clinical and Pathological Study of Primary Liver Cancer. 2nd ed. Tokyo: Kaneharap 2003.Google Scholar
  9. 9.
    Kojiro M, Kawabata K, Kawano Y, Shirai F, Takemoto N, Nakashima T. Hepatocellular carcinoma presenting as intrabile duct tumor growth: a clinicopathologic study of 24 cases. Cancer 1982;49:2144–2147. doi: 10.1002/1097-0142(19820515)49:10<2144::AID-CNCR2820491026>3.0.CO;2-O.PubMedCrossRefGoogle Scholar
  10. 10.
    Shiomi M, Kamiya J, Nagino M, Uesaka K, Sano T, Hayakawa N, Kanai M, Yamamoto H, Nimura Y. Hepatocellular carcinoma with biliary tumor thrombi: aggressive operative approach after appropriate preoperative management. Surgery 2001;129:692–698. doi: 10.1067/msy.2001.113889.PubMedCrossRefGoogle Scholar
  11. 11.
    Qin LX, Ma ZC, Wu ZQ, Fan J, Zhou XD, Sun HC, Ye QH, Wang L, Tang ZY. Diagnosis and surgical treatments of hepatocellular carcinoma with tumor thrombosis in bile duct: experience of 34 patients. World J Gastroenterol 2004;10:1397–1401.PubMedGoogle Scholar
  12. 12.
    Wind G, Futterman S. Obstructive jaundice secondary to hepatoma. Case report and literature review. Am J Gastroenterol 1977;67:80–83.PubMedGoogle Scholar
  13. 13.
    Kew MC, Paterson AC. Unusual clinical presentations of hepatocellular carcinoma. Trop Gastroenterol 1985;6:10–22.PubMedGoogle Scholar
  14. 14.
    Lai ST, Lam KT, Lee KC. Biliary tract invasion and obstruction by hepatocellular carcinoma: report of five cases. Postgrad Med J 1992;68:961–963.PubMedCrossRefGoogle Scholar
  15. 15.
    Peng SY, Wang JW, Liu YB, Cai XJ, Deng GL, Xu B, Li HJ. Surgical intervention for obstructive jaundice due to biliary tumor thrombus in hepatocellular carcinoma. World J Surg 2004;28:43–46. doi: 10.1007/s00268-003-7079-4.PubMedCrossRefGoogle Scholar
  16. 16.
    Lee NW, Wong KP, Siu KF, Wong J. Cholangiography in hepatocellular carcinoma with obstructive jaundice. Clin Radiol 1984;35:119–123. doi: 10.1016/S0009-9260(84)80008-2.PubMedCrossRefGoogle Scholar
  17. 17.
    Lau WY, Leung KL, Leung TW, Ho S, Chan M, Liew CK, Leung N, Johnson P, Li AK. Obstructive jaundice secondary to hepatocellular carcinoma. Surg Oncol 1995;4:303–308.PubMedCrossRefGoogle Scholar
  18. 18.
    AJCC. AJCC cancer staging manual. 6th ed. New York: Springer, 2002.Google Scholar
  19. 19.
    Minagawa M, Ikai I, Matsuyama Y, Yamaoka Y, Makuuchi M. Staging of hepatocellular carcinoma: assessment of the Japanese TNM and AJCC/UICC TNM systems in a cohort of 13,772 patients in Japan. Ann Surg 2007;245:909–992. doi: 10.1097/01.sla.0000254368.65878.da.PubMedCrossRefGoogle Scholar
  20. 20.
    Fukuda S, Okuda K, Imamura M, Imamura I, Eriguchi N, Aoyagi S. Surgical resection combined with chemotherapy for advanced hepatocellular carcinoma with tumor thrombus: report of 19 cases. Surgery 2002;131:300–310. doi: 10.1067/msy.2002.120668.PubMedCrossRefGoogle Scholar
  21. 21.
    Schwartz JD, Schwartz M, Mandeli J, Sung M. Neoadjuvant and adjuvant therapy for resectable hepatocellular carcinoma: review of the randomised clinical trials. Lancet Oncol 2002;3:593–603. doi: 10.1016/S1470–2045(02)00873–2.PubMedCrossRefGoogle Scholar

Copyright information

© The Society for Surgery of the Alimentary Tract 2008

Authors and Affiliations

  • Naoki Ikenaga
    • 1
  • Kazuo Chijiiwa
    • 1
  • Kazuhiro Otani
    • 1
  • Jiro Ohuchida
    • 1
  • Shuichiro Uchiyama
    • 1
  • Kazuhiro Kondo
    • 1
  1. 1.Department of Surgical Oncology and Regulation of Organ FunctionMiyazaki University School of MedicineKiyotakeJapan

Personalised recommendations